期刊名称:CLINICAL RESPIRATORY JOURNAL
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
Instructions to Authors
1. Editorial policies and procedures
The Clinical Respiratory Journal (CRJ) provides a rapid-response forum for publishing clinical research in all areas of respiratory medicine from clinical lung disease to basic research relevant to the clinic.
CRJ will not consider manuscripts that have been published previously or that are under consideration for publication elsewhere, and the submission should include a cover letter clearly stating that neither is the case.
Manuscripts will be peer-reviewed. At the discretion of the Editor-in-Chief, the submitted manuscript may be rejected immediately, without full review, for instance if it falls outside of the aims and scope of the journal or if it does not comply with international ethical standards (see below).
Authorship All persons listed as authors must have contributed substantially to the design, performance, analysis, or reporting of the work and are required to indicate their specific contribution. The specific requirements for authorship have been defined by the International Committee of Medical Journal Editors (ICMJE; http://www.icmje.org). Examples of authors鈥?contributions are: 'designed research/study', 'performed research/study', 'contributed important reagents', 'collected data', 'analyzed data', 'wrote paper' etc. This information must be included in the title page of the manuscript and will be published if the paper is accepted for publication. The corresponding author is responsible for obtaining permission from all co-authors for the submission of any version of the manuscript and for any changes in authorship.
Acknowledgements All contributors who do not meet the criteria for authorship must be listed in an acknowledgements section at the end of the manuscript. Financial and material support must also be acknowledged. Authors are required to describe the role of the study sponsor(s), if any, in study design; in collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the manuscript for publication. If the supporting source had no such involvement, the authors should state so.
Conflicts of Interest When submitting a manuscript, whether a review article, an original article, a case report, a letter or an editorial, authors are responsible for disclosing all financial and personal relationships that could be viewed as presenting a potential conflict of interest. To prevent ambiguity, all authors must state explicitly whether potential conflicts do or do not exist. This information will be included on the title page of the published article. Authors must include the statement in the manuscript on a conflicts of interest notification page following the title page, providing additional detail, if necessary, in a cover letter accompanying the manuscript.
Ethics Manuscripts must contain a statement, immediately prior to the Introduction section at the beginning of the text, to the effect that all human studies have been reviewed by the appropriate ethics committee and been performed in accordance with the ethical standards laid down in an appropriate version of the 2000 Declaration of Helsinki (http://www.wma.net/e/policy/b3.htm). It should also be clearly stated in the statement that all persons gave their informed consent prior to their inclusion in the study. Epidemiological studies, quality assurance studies and similar retrospective data collections may fall outside these requirements. Details that might disclose the identity of the subjects under the study should be omitted. CRJ does not publish articles which report experiments on animals.
Clinical Trials CRJ will consider publishing only trials that have been registered in a public trials registry. The name of the registry and the registration number should be stated at the end of the abstract of the manuscript. Trials must be registered at the time or before patients are enrolled. We define clinical trials according to ICMJE, as any research project that prospectively assigns human subjects to intervention or comparison groups to study the cause and effect relationship between a medical intervention and a health outcome. Studies designed for other purposes, such as to study pharmacokinetics or major toxicity (e.g., phase I trials), would be exempt.
Registration must take place at a registry that meets the following minimum criteria:
- Accessible to the public at no charge.
- Searchable by standard electronic (internet-based) methods.
- Open to all prospective registrants free of charge or at a minimal fee.
- Validates registered information.
- Identifies trials with a unique number.
- Includes information on: the investigator(s), research question or hypothesis, methodology, intervention and comparisons, eligibility criteria, primary and secondary outcomes measured, date of registration, anticipated or actual start date, anticipated or actual date of last follow-up, target number of subjects, status (anticipated, ongoing or closed), and funding source(s)
Registries that currently meet these criteria include:
- The registry sponsored by the U.S. National Library of Medicine (www.clinicaltrials.gov).
- The International Standard Randomised Controlled Trail Number Registry (www.controlled-trials.com).
- The Cochrane Renal Group registry (www.cochrane-renal.org/trialsubmissionform.php).
- The National (U.K.) Research Register (www.update-software.com/national).
The Editor-in-Chief reserves the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfil the above mentioned requirements.
Copyright All submitted manuscripts must be accompanied by a completed Copyright Transfer Agreement faxed and mailed to the Editorial Office:
Fax: +45 35312179
The Clinical Respiratory Journal Respiratory and Allergy Research Unit Department of Respiratory Medicine Bispebjerg University Hospital DK-2400 Copenhagen NV Denmark
The work shall not be published elsewhere in any language without the written consent of the Publisher. The articles published in this Journal are protected by the licence, which covers translation rights and the exclusive right to reproduce and distribute all of the articles printed in the Journal. No material published in the Journal may be stored on microfilm or videocassettes or in any kind of electronic database or reproduced photographically without the prior written permission of the Publisher.
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley InterScience, as well as deposited in the funding agency's preferred archive. For the full list of terms and conditions, see http://www3.interscience.wiley.com/authorresources/onlineopen.html#OnlineOpen_Terms.
Any authors wishing to send their paper for OnlineOpen will be required to complete the payment form available from our website at: http://www.blackwellpublishing.com/pdf/oof_crj.pdf
Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper as OnlineOpen if you do not wish to. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.
Any author wishing to send their paper for OnlineOpen will be required to complete the combined payment and copyright licence form.
(Please note this form is for use with OnlineOpen material ONLY.)
Once complete this form should be sent to the Editorial Office along with the rest of the manuscript materials at the time of acceptance or as soon as possible after that (preferably within 24 hours to avoid any delays in processing). Prior to acceptance there is no requirement to inform an Editorial Office that you intend to publish your paper OnlineOpen if you do not wish to.
2. Submission of papers
Only electronic submissions will be considered. Please submit your paper online via http://mc.manuscriptcentral.com/crj
Electronic File Formats Manuscript text must be saved in Word (.doc), Wordperfect (.wpd) or Rich text Format (.rtf). Do not submit text in PDF format (.pdf). Authors should note that Word 2007 is not yet compatible with journal production systems. Unfortunately, the journal cannot accept Microsoft Word 2007 documents until such time as a stable production version is released. Please use Word鈥檚 鈥楽ave As鈥?option therefore to save your document as an older (.doc) file type. Figures must be saved as separate figure files. GIF, JPEG, PICT or Bitmap files are acceptable for submission, but only TIFF or EPS files are suitable for printing. After acceptance, you will be contacted to provide print-quality figures if you have not already done so. NOTE: If you鈥檙e able to supply figures PDF format (.pdf) only they must be distilled using the 'Print Optimised' option.
3. Manuscript types and preparation
Review Article Review articles should be no more than 3500 words. For review articles authors should prepare a structured abstract of no more than 250 words followed by 4鈥? keywords (MeSH terms) on the same page.
Preferred structure of review articles Abstract
- Objectives
- Data source
- Study selection
- Results
- Conclusion
Data source: summarize briefly the data source, including time restrictions and exact indexing terms used for article retrieval from any bibliographic databases, including restrictions to any specific language such as English or to human subjects.
Study selection: Describe criteria used to select studies for detailed review from those identified as relevant to the topic.
Original Article Original articles should be divided into the following sections (each section beginning on a new page):
- Title page
- Abstract
- Introduction
- Materials and methods
- Results
- Discussion
- Acknowledgements (if any)
- References
- Figure Legends
- Tables
The title page should include a concise and informative title of no more than 20 words, a list of all authors with full first names and affiliations, with a clear indication of who is associated with each institution, and full correspondence details of the corresponding author, including email address and fax number. Authors should be limited to those individuals who contributed in an important manner to the study design, data, collection and analysis, or writing of the manuscript. Please list a description of each author鈥檚 contribution or role, e.g. 鈥渄esigned research/study鈥? 鈥減erformed research/study鈥? 鈥渃ontributed important reagents鈥? 鈥渃ollected data鈥? 鈥渁nalyzed data鈥? 鈥渨rote the paper鈥?etc.
The abstract should not exceed 250 words and should be structured by Introduction, Objectives, Methods, Results and Conclusion, followed by 4鈥? keywords (MeSH terms).
Body of the paper (Introduction, Materials and Methods, Results and Discussion) should not exceed 3000 words.
References should be numbered in the order in which they are first cited in the text. Titles of journals should be abbreviated according to the style used in Index Medicus. Examples:
1. Journal articles: Thomsen SF, Ulrik CS, Kyvik KO, Larsen K, Skadhauge LR, Steffensen I, Backer V. The incidence of asthma in young adults. Chest. 2005;127:1928-34.
2. Book chapter: Storm BC. Asthma. In: Thompson VC, Olson O, editors. Pulmonary Pathophysiology. Baltimore: Williams & Wilkins; 1990. p. 27-42.
Tables and/or figures should be limited to maximum of 8 altogether. Tables less than 2 pages (approximately 90 rows) should be included at the end of the manuscript. Longer tables should be submitted, and referred to in the text, as supplementary material. Figure files must be saved as separate figure files not embedded in the main text. GIF, JPEG, PICT or Bitmap files are acceptable for submission, but only TIFF (for photographic images) or EPS (for line art and combinations of photographs and labelling) files are suitable for printing. After acceptance, you will be contacted to provide print-quality figures if you have not already done so. Any colour illustrations must be paid for by the author. Colour artwork in accepted manuscripts must be accompanied by a colour work agreement form. Before your article can be published the form must be completed, and faxed to the Editorial Office at +45 35312179.
Case Report Case reports should follow the same pattern as original articles (see above), but the total length should not exceed 1500 words including the abstract but excluding the references, tables and figures. Only cases of exceptional interest and novelty will be considered together with an overview and discussion of relevant literature.
Letter to the Editor Letters to the Editor are welcomed but should be limited to 700 words and no more than 10 references. No abstract and keywords required.
Editorial If asked for an editorial, it would most often be in relation to one or more articles of specific interest. Editorials should be limited to 700 words and no more than 3 references.
Forum Under the "Forum" heading CRJ publishes short communications on topics with specific interest for Nordic readers, for example short meeting reports, 'educational cases' (with no abstract) or commentaries of not more than 500 words. Also selected abstracts from Nordic PhD theses will be considered, and should also be kept at maximum 500 words. These should be organised like a structured abstract with introduction, objective, methods, results and conclusion, followed by 4-7 keywords (MeSH terms).
Book Review Book Reviews of maximum 700 words are welcome.
References in articles We recommend the use of a tool such as EndNote or Reference Manager for reference management and formatting. EndNote reference styles can be searched for here: http://www.endnote.com/support/enstyles.asp. Reference Manager reference styles can be searched for here: http://www.refman.com/support/rmstyles.asp.
4. Accepted articles
Electronic artwork When submitting artwork electronically, please read the information on the Blackwell Publishing website at: http://www.blackwellpublishing.com/bauthor/digill.asp
Preparation of electronic artwork Although low-quality images are adequate for review purposes, print publication requires high-quality images to prevent the final product being blurred or fuzzy. For further details, see the Publisher鈥檚 guidelines at http://authorservices.wiley.com/bauthor/illustration.asp.
- Submit EPS (line art) or TIFF (half-tone/photographs) files only.
- For scanned images, the scanning resolution (at final image size, see above for a guide to sizes) should be as follows to ensure adequate reproduction: line art, >800 dpi; half-tones (including gel photographs), >300 dpi. Figures containing both half-tone and line images, >600 dpi.
- EPS files should be saved with fonts embedded (and with a TIFF preview if possible).
- Black and white images should be supplied as 鈥榞rayscale鈥?
- Colour images should be supplied as CMYK.
- Multipart figures should be supplied in the final layout in one file.
We therefore recommend that authors generate their artwork in software packages incorporating a 鈥楽AVE AS鈥?or 鈥楨XPORT鈥?TIFF/EPS function, e.g. Adobe Illustrator 7.0 and above, Deneba Canvas 6.0 and above (EPS), CorelDraw 7.0 and above (EPS), Adobe Photoshop 4.0 and above (TIFF). You can EXPORT low resolution figs (GIF/JPG) from these packages for review purposes. EPS files can be produced from other applications (eg PowerPoint_[see http://authorservices.wiley.com/bauthor/illustration.asp]. BUT results
can be unpredictable (e.g. fonts and shading not converted correctly, lines missing, dotted lines becoming solid). For full instructions see http://authorservices.wiley.com/bauthor/illustration.asp
All scanned images embedded into other applications should be scanned at the recommended resolutions (see above).
Proofs Page proofs will be sent to the corresponding author and should be returned within 3 days of receipt to the Production Editor. Significant textual alterations are unacceptable at proof stage without the written approval of the Editor-in-Chief, and they are likely to result in delay of publication.
The corresponding author will receive an e-mail alert containing a link to a secure web site. A working e-mail address must therefore be provided for the corresponding author. In your absence, please arrange for a colleague to access your e-mail to retrieve the proofs.
The proof can be downloaded as a PDF (portable document format) file from the site. Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the following web site: http://www.adobe.com/products/acrobat/readstep2.html. This will enable the file to be opened, read on screen and printed out in order or any corrections to be added. Further instructions will be sent with the proof.
Please note that you have final responsibility for what is stated in the proofs of your manuscript.
Offprints Free access to the final PDF offprint will be available via author services only. Please therefore sign up for author services if you would like to access your article PDF offprint and enjoy the many other benefits the service offers.
Early View The Clinical Respiratory Journal is covered by Blackwell Publishing's Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles mean that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continued to be used to cite and access the article. More information about DOIs can be found at http://www.doi.org/faq.html
Author Services Online production tracking is now available for your article through Blackwell's Author Services
Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://authorservices.wiley.com/bauthor/ for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.
Author material archive policy Please note that unless specifically requested, Blackwell Publishing will dispose of all hardcopy or electronic material submitted two months after publication. If you require the return of any material submitted, please inform the Editorial Office or Production Editor as soon as possible if you have not yet done so.
Disclaimer The Publisher, The Nordic Respiratory Academy, and the Editor-in-Chief cannot be held responsible for errors or any consequences arising from the use of information contained in the journal, the views and opinions expressed do not necessarily reflect those of the Publisher, Societies and the Editors, neither does the publication of advertisements constitute any endorsement by the Publisher, Societies and Editors of the products advertised.
Editorial Board
EDITOR-IN-CHIEF Vibeke Backer, Copenhagen, Denmark
ADVISORY EDITOR Ronald Dahl, Aarhus, Denmark
EDITORIAL SECRETARY Marianne Boeje, Copenhagen, Denmark
EDITORIAL OFFICE Respiratory and Allergy Research Unit Department of Respiratory Medicine L Bispebjerg University Hospital DK-2400 Copenhagen NV Denmark Tel: +45 35313569 Fax: +45 35312179 E-mail: mb07@bbh.regionh.dk
EDITORIAL BOARD
Asthma, rhinitis and allergy Alan Altraja, Tartu, Estonia Wytske Fokkens, Amsterdam, the Netherlands Qutayba Hamid, Montreal, Canada Eyth贸r Hreinn Bj枚rnsson, Reykjavik, Iceland Johny Kongerud, Oslo, Norway Allan Linneberg, Copenhagen, Denmark Bo Lundback, Stockholm, Sweden Ernst Omenaas, Bergen, Norway Jacob Sont, Leiden, the Netherlands Charlotte Suppli Ulrik, Copenhagen, Denmark
Airway hyperresponsiveness, sport and genetics Sandy Anderson, Sydney, Australia Leif Bjermer, Lund, Sweden Sven-Erik Dahlen, Stockholm, Sweden Ed K Silverman, Boston, MA, USA Malcolm Sue-Chu, Trondheim, Norway Scott Weiss, Boston, MA, USA Maritta S Jaakkola, Oulu, Finland
COPD, non-invasive ventilation and epidemiology Per Bakke, Bergen, Norway Sonia Buist, Portland, OR, USA Amund Gulsvik, Bergen, Norway David M Mannino, Lexington, KY, USA Marc Miravitlles, Barcelona, Spain Don D Sin, Vancouver, Canada J酶rgen Vestbo, Copenhagen, Denmark Giovanni Viegi, Piza, Italy Wisia Wedzicha, London, UK Thomas Ringb忙k, Copenhagen, Demark Russell Bowler, Denver, CO, USA
Interstitial lung diseases Ron du Bois, Denver, CO, USA Jim Egan, Dublin, Ireland Johan Gr眉newald, Stockholm, Sweden Patricia Haslam, London, UK Riita Kaarteenaho-Wiik, Oulu, Finland James Utz, Rochester, MN, USA
Lung infections Olafur Baldursson, Reykjavik, Iceland Torsten Bauer, Berlin, Germany Francesco Blasi, Milan, Italy Sebastian Johnston, London, UK
Lung cancer and clinical physiology Jens Benn S酶rensen, Copenhagen, Denmark Steinn J贸nsson, Reykjavik, Iceland Robert Loddenkemper, Berlin, Germany Jann Mortensen, Copenhagen, Denmark Martin Reck, Grosshansdorf, Germany Anssi Sovij盲rvi, Helsinki, Finland Stephen Spiro, London, UK Einar Thorsen, Bergen, Norway
Sleeping disorders Thorarinn Gislason, Reykjavik, Iceland Christer Janson, Uppsala, Sweden Turkka Kirjavainen, Helsinki, Finland Patrick L茅vy, Grenoble, France Walter McNicholas, Dublin, Ireland
Pediatrics Kai-Haakon Carlsen, Oslo, Norway Bradley E. Chipps, Sacramento, CA, USA Hakon Hakonarson, Philadelphia, USA Thomas Halvorsen, Bergen, Norway Gerard Koppelman, Groningen, the Netherlands Kim G. Nielsen, Copenhagen, Denmark James Y. Paton, Glascow, UK Giovanni Piedimonto, Morgantown, WV, USA Hiran Selvadurai, Westmead, Australia Peter Van Asperen, Westmead, Australia
|